Recent Developments on Phenstatins as Potent Antimitotic Agents

被引:7
|
作者
Chen, Xing [1 ]
Wang, Shi-Meng [1 ]
Kumar, Gajjela Bharath [1 ]
Bare, Grant A. L. [2 ]
Leng, Jing [1 ]
Bukhari, Syed Nasir Abbas [1 ,3 ]
Qin, Hua-Li [1 ]
机构
[1] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Dept Pharmaceut Engn, 205 Luoshi Rd, Wuhan 430070, Hubei, Peoples R China
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Aljouf 2014, Sakaka, Saudi Arabia
关键词
Structure-activity relationship; Cytotoxic activity; Antimitotic activity; Tubulin polymerization inhibition; Colchicine binding site; phenstatins; TUBULIN POLYMERIZATION INHIBITORS; VASCULAR DISRUPTING AGENT; ISOCOMBRETASTATIN A-4 ANALOGS; DERIVATIVE AVE8062 AC7700; BREAST-CANCER CELLS; BLOOD-FLOW STASIS; BIOLOGICAL EVALUATION; COMBRETASTATIN A-4; ANTITUBULIN AGENTS; ANTICANCER AGENTS;
D O I
10.2174/0929867324666171106162048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Phenstatin and their derivatives display remarkable antiproliferative activity toward a wide variety of preclinical tumor models. Structural simplicity and excellent stability of phenstatins offer a stimulating premise for developing various derivatives with profound antimitotic activity and excellent cytotoxicity. Objective: To do analysis of literature that phenstatins derivatives inhibit tubulin polymerization through their interaction at the colchicine binding site of microtubules and arrest the G2/M phase of the cell cycle. In addition, phenstatin derivatives are undergoing clinical evaluation as vascular targeting/disrupting agents and also exhibit direct antiangiogenic properties. Methods: An organised well designed and appropriately managed search of bibliographic databases for peer-reviewed research literature using a focused review question and inclusion/exclusion criteria has been done for this article. Conclusion: In this review article, the synthesis and structure-activity relationships of phenstatin and a wide number of their reported analogues with modifications to ring A, ring B, and to the keto position are discussed in the perspective of medicinal chemistry with proper conclusion.
引用
收藏
页码:2329 / 2352
页数:24
相关论文
共 50 条
  • [1] Recent developments of the antimitotic agents
    Nam, NH
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (13) : 1593 - 1594
  • [2] Novel sulfonate derivatives: Potent antimitotic agents
    Gwaltney, SL
    Imade, HM
    Li, Q
    Gehrke, L
    Credo, RB
    Warner, RB
    Lee, JY
    Kovar, P
    Frost, D
    Ng, SC
    Sham, HL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (13) : 1671 - 1673
  • [3] Benzopyridooxathiazepine derivatives as novel potent antimitotic agents
    Gallet, Sebastien
    Flouquet, Nathalie
    Carato, Pascal
    Pfeiffer, Bruno
    Renard, Pierre
    Leonce, Stephane
    Pierre, Alain
    Berthelot, Pascal
    Lebegue, Nicolas
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (03) : 1132 - 1138
  • [4] Novel diarylsulfonylurea derivatives as potent antimitotic agents
    Kim, S
    Park, JH
    Koo, SY
    Kim, JI
    Kim, MH
    Kim, JE
    Jo, K
    Choi, HG
    Lee, SB
    Jung, SH
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6075 - 6078
  • [5] ISOCOMBRETASTATINS A. A HIGHLY POTENT FAMILY OF ANTIMITOTIC AGENTS
    Alvarez, Raquel
    Alvarez, Concepcion
    Pelaez, Rafael
    Medarde, Manuel
    [J]. DRUGS OF THE FUTURE, 2009, 34 : 148 - 148
  • [6] Novel sulfonate derivatives: Potent antimitotic agents.
    Gwaltney, SL
    Imade, HM
    Barr, KJ
    Li, Q
    Gehrke, L
    Credo, RB
    Warner, RB
    Lee, JY
    Nukkala, MA
    Zielinski, NA
    Frost, D
    Sham, HL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U24 - U24
  • [7] Potent, bioavailable, and efficacious oxazoline antimitotic agents.
    Gwaltney, SL
    Barr, KJ
    Wang, L
    Claiborne, A
    Jae, HS
    Liu, G
    Imade, HM
    Woods, KW
    McCroskey, RW
    Li, Q
    Tasker, AS
    Von Geldern, T
    Gehrke, L
    Credo, RB
    Warner, RB
    Lee, JY
    Hui, YH
    Marsh, K
    Nukkala, M
    Zielinski, NA
    Frost, D
    Rosenberg, S
    Sham, HL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U28 - U28
  • [8] Recent progress in discovery and development of antimitotic agents
    Kiselyov, Alex
    Balakin, Konstantin V.
    Tkachenko, Sergey E.
    Savchuk, Nikolay
    Ivachtchenko, Alexandre V.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 189 - 208
  • [9] Novel sulfonate analogues of combretastatin A-4: Potent antimitotic agents
    Gwaltney, SL
    Imade, HM
    Barr, KJ
    Li, Q
    Gehrke, L
    Credo, RB
    Warner, RB
    Lee, JY
    Kovar, P
    Wang, JY
    Nukkala, MA
    Zielinski, NA
    Frost, D
    Ng, SC
    Sham, HL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (07) : 871 - 874
  • [10] POTENT ANTILEUKEMIC AND ANTIMICROBIAL ACTIVITY OF THE NOVEL ANTIMITOTIC AGENTS AVARONE AND AVAROL
    MULLER, WEG
    ZAHN, RK
    MAIDHOF, A
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 78 - 78